Ignite Creation Date:
2024-06-16 @ 11:50 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06447415
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2024-06-03
Brief Title:
Safety Tolerability and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke a Multi-center Randomized Double-blind Double-dummy Placebo-controlled Clinical Trial
Sponsor:
Fujian Shengdi Pharmaceutical Co Ltd
Organization:
Fujian Shengdi Pharmaceutical Co Ltd
Study Overview
Official Title:
Safety Tolerability and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke a Multi-center Randomized Double-blind Double-dummy Placebo-controlled Single Dose Incremental Phase Ib Clinical Trial
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a multi-center randomized double-blind double-dummy placebo-controlled single dose escalation study aimed at evaluating the overall safety tolerability and preliminary efficacy of HRS-7450 in patients with acute ischemic stroke
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None